UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by CFS Investment Advisory Services LLC

CFS Investment Advisory Services LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 15.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,904 shares of the healthcare conglomerate’s stock after acquiring an additional 387 shares during the period. CFS Investment Advisory Services LLC’s holdings in UnitedHealth Group were worth $1,469,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Dark Forest Capital Management LP grew its holdings in shares of UnitedHealth Group by 76.9% in the second quarter. Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock valued at $374,000 after purchasing an additional 319 shares in the last quarter. Scientech Research LLC purchased a new position in UnitedHealth Group in the second quarter worth approximately $1,071,000. Sepio Capital LP increased its position in shares of UnitedHealth Group by 0.3% in the 2nd quarter. Sepio Capital LP now owns 5,822 shares of the healthcare conglomerate’s stock valued at $2,965,000 after purchasing an additional 20 shares during the last quarter. Texas Capital Bank Wealth Management Services Inc lifted its position in shares of UnitedHealth Group by 6.6% during the 2nd quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,134 shares of the healthcare conglomerate’s stock worth $8,216,000 after purchasing an additional 994 shares during the last quarter. Finally, Kathmere Capital Management LLC raised its stake in UnitedHealth Group by 25.1% in the second quarter. Kathmere Capital Management LLC now owns 4,768 shares of the healthcare conglomerate’s stock valued at $2,428,000 after buying an additional 958 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

UNH stock opened at $532.26 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market cap of $489.83 billion, a price-to-earnings ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. The firm has a 50 day moving average of $541.04 and a 200-day moving average of $563.84. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the business earned $5.83 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.58%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on UNH. Royal Bank of Canada cut their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Stephens lifted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.